DK44788A - Svaekket cytomegalovirus, vaccine indeholdende et saadant virus og dna-konstruktion - Google Patents

Svaekket cytomegalovirus, vaccine indeholdende et saadant virus og dna-konstruktion

Info

Publication number
DK44788A
DK44788A DK044788A DK44788A DK44788A DK 44788 A DK44788 A DK 44788A DK 044788 A DK044788 A DK 044788A DK 44788 A DK44788 A DK 44788A DK 44788 A DK44788 A DK 44788A
Authority
DK
Denmark
Prior art keywords
cytomegalovirus
weakly
virus
vaccine containing
dna construction
Prior art date
Application number
DK044788A
Other languages
Danish (da)
English (en)
Other versions
DK44788D0 (da
Inventor
Edward S Mocarski
Richard R Spaete
Original Assignee
Univ Leland Stanford Junior
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leland Stanford Junior filed Critical Univ Leland Stanford Junior
Publication of DK44788D0 publication Critical patent/DK44788D0/da
Publication of DK44788A publication Critical patent/DK44788A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16741—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK044788A 1987-01-30 1988-01-29 Svaekket cytomegalovirus, vaccine indeholdende et saadant virus og dna-konstruktion DK44788A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US927387A 1987-01-30 1987-01-30

Publications (2)

Publication Number Publication Date
DK44788D0 DK44788D0 (da) 1988-01-29
DK44788A true DK44788A (da) 1988-07-31

Family

ID=21736649

Family Applications (1)

Application Number Title Priority Date Filing Date
DK044788A DK44788A (da) 1987-01-30 1988-01-29 Svaekket cytomegalovirus, vaccine indeholdende et saadant virus og dna-konstruktion

Country Status (3)

Country Link
EP (1) EP0277773A1 (ja)
JP (1) JPS63267272A (ja)
DK (1) DK44788A (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE118822T1 (de) * 1987-06-26 1995-03-15 Syntro Corp Rekombinanter, fremde gene enthaltender menschlicher cytomegalovirus und seine verwendung.
GB2214508A (en) * 1988-01-27 1989-09-06 Bayer Ag Plasmid vector for the efficient expression of foreign genes fused with newly conceived transcriptional and translational signal sequences.
US5552143A (en) * 1989-03-24 1996-09-03 The Wistar Institute Of Anatomy & Biology Recombinant cytomegalovirus vaccine
DK0389286T3 (da) * 1989-03-24 1996-11-18 Wistar Inst Rekombinant-cytomegalovirus-vaccine
US5180813A (en) * 1989-03-24 1993-01-19 University Of Iowa Research Foundation Early envelope glycoprotein of human cytomegalovirus (hmcv) and monoclonal antibodies to the glycoproteins
US5591439A (en) * 1989-03-24 1997-01-07 The Wistar Institute Of Anatomy And Biology Recombinant cytomegalovirus vaccine
US7223411B1 (en) 1992-07-31 2007-05-29 Dana-Farber Cancer Institute Herpesvirus replication defective mutants
US5801235A (en) * 1994-05-25 1998-09-01 Hybridon, Inc. Oligonucleotides with anti-cytomegalovirus activity
EP0914441A2 (en) 1996-04-23 1999-05-12 The Wistar Institute Of Anatomy And Biology Novel human cytomegalovirus dna constructs and uses therefor
US6399354B1 (en) 1998-07-31 2002-06-04 President And Fellows Of Harvard College Replication-competent virus expressing a detectable fusion protein
AU2001288682A1 (en) 2000-08-30 2002-03-13 Chemocentryx, Inc. Inhibition of cmv infection and dissemination
WO2002062296A2 (en) * 2001-02-02 2002-08-15 Chemocentryx, Inc. Methods and compositions useful for stimulating an immune response
EP3475446A1 (en) 2016-06-27 2019-05-01 Juno Therapeutics, Inc. Method of identifying peptide epitopes, molecules that bind such epitopes and related uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959466A (en) * 1974-04-15 1976-05-25 The Wistar Institute Highly attenuated cytomegalovirus vaccine and production thereof
US4058598A (en) * 1974-10-18 1977-11-15 Harold Stern Cytomegalovirus attenuation method and vaccine
CA1282721C (en) * 1984-06-04 1991-04-09 Bernard Roizman Herpes simplex virus as a vector

Also Published As

Publication number Publication date
EP0277773A1 (en) 1988-08-10
JPS63267272A (ja) 1988-11-04
DK44788D0 (da) 1988-01-29

Similar Documents

Publication Publication Date Title
DK112586A (da) Virus-dna
DK81290D0 (da) Rekombinante bakterier og malariavaccine indeholdende disse
FI864016A0 (fi) Med rekombinant-dna-teknik erhaollen kolonistimulerande faktor-1.
DK56086A (da) 11beta-phenylgonaner, deres fremstilling og farmaceutiske indeholdende dem
DK290986A (da) 2-arylimidazolforbindelser, laegemidler indeholdende disse forbindelser og deres fremstilling
DK288184A (da) 13alfa-alkylgonaner, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK272889A (da) Vaccine
DK122687D0 (da) Polypeptid, dna og anvendelse deraf
DK38989D0 (da) Dna-sekvens
DK518687D0 (da) Imidazo-benzoxazinoner, deres fremstilling og laegemidler indholdende forbindelserne
DK209188D0 (da) Bifunktionelle proteiner, deres fremstilling og anvendelse som laegemiddel
DK44788A (da) Svaekket cytomegalovirus, vaccine indeholdende et saadant virus og dna-konstruktion
FR2620459B1 (fr) Virus recombinant de la vaccine
DK189788D0 (da) Vaccine
DK127887D0 (da) Interleukin-1beta-derivater og medikamenter indeholdende saadanne derivater
DK166583C (da) 1-pyrimidinyloxy-3-alkylamino-2-propanoler, deres fremstilling og farmaceutiske praeparater indeholdende disse
DK199989A (da) Angucyclinoner fra streptomyceter, deres fremstilling og anvendelse
DK698188A (da) Peptider, deres fremstilling og anvendelse
DK319888A (da) Dna-fragmenter
DK151788A (da) Hybridserpiner og dna, som koder derfor
DK578189D0 (da) Dna-sekvens
DK202089A (da) Angucyclinoner fra streptomyceter, deres fremstilling og anvendelse
DK448687A (da) Dna, der koder for et virusantigen
GB8712042D0 (en) Virus & vaccine
IT8522033A0 (it) Procedimento per la sua vaccino a virus inattivato e preparazione.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment